ABBV
AbbVie
ABBV
Meridian score68
4 of 5 factors measured. Quality is not measured for this company.
QualityNo data
MomentumMomentum: 89th percentile
GrowthGrowth: 77th percentile
ValuationValuation: 30th percentile
ExpectationsExpectations: 22nd percentile
ResearchNot researched
Evidence to review
- Financial comparability: Goodwill and intangible assets increased materially; review acquisition effects.
Stage and trend
Stage 2 · AdvancingAbove 21d: yesAbove 50d: yesAbove 200d: yes50d over 200d: yes
Weeks in stage18 · week open
30-week lineRising
From 30-week line+18.4%
Price · Oct 27$286.39
From 52w high-1.7%
Relative volume0.6x
1M+8.2%
3M+9.4%
6M+46.8%